Does monoamine oxidase A suppress hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling?
Taken together, the results of our study may provide insights into the application of MAOA as a novel predictor of clinical outcomes and indicate that increasing MAOA expression or enzyme activity may be a new approach that can be used for HCC treatment.
PGE1 attenuated the impairment of cellular immunity after cardiac surgery with CPB by reducing oxidative stress on PBMCs.